Andrea M Russo

Summary

Affiliation: University of Pennsylvania
Country: USA

Publications

  1. doi request reprint Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial
    Andrea M Russo
    University of Pennsylvania Health System, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    J Cardiovasc Electrophysiol 19:720-4. 2008
  2. ncbi request reprint Defibrillation threshold testing: is it really necessary at the time of implantable cardioverter-defibrillator insertion?
    Andrea M Russo
    University of Pennsylvania Health System, Philadelphia, Pennsylvania 19104, USA
    Heart Rhythm 2:456-61. 2005
  3. ncbi request reprint Incidence and predictors of very late recurrence of atrial fibrillation after ablation
    Sumeet K Mainigi
    Electrophysiology Section, Division of Cardiovascular Medicine, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    J Cardiovasc Electrophysiol 18:69-74. 2007
  4. doi request reprint Long-term clinical efficacy and risk of catheter ablation for atrial fibrillation in the elderly
    Erica Zado
    Cardiovascular Division, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA
    J Cardiovasc Electrophysiol 19:621-6. 2008
  5. ncbi request reprint Surface electrocardiogram characteristics of atrial tachycardias occurring after pulmonary vein isolation
    Edward P Gerstenfeld
    Section of Cardiac Electrophysiology, Division of Cardiology, Department of Medicine, University of Pennsylvania Health System, Philadelphia, Pennsylvania 19104, USA
    Heart Rhythm 4:1136-43. 2007
  6. doi request reprint Single procedure efficacy of isolating all versus arrhythmogenic pulmonary veins on long-term control of atrial fibrillation: a prospective randomized study
    Sanjay Dixit
    Cardiovascular Division, Hospital of The University of Pennsylvania and Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Heart Rhythm 5:174-81. 2008
  7. doi request reprint Antiarrhythmics after ablation of atrial fibrillation (5A Study): six-month follow-up study
    Peter Leong-Sit
    Cardiac Electrophysiology Section, Cardiovascular Division, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
    Circ Arrhythm Electrophysiol 4:11-4. 2011
  8. doi request reprint Antiarrhythmics After Ablation of Atrial Fibrillation (5A Study)
    Jean Francois Roux
    Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA
    Circulation 120:1036-40. 2009
  9. ncbi request reprint Influence of gender on arrhythmia characteristics and outcome in the Multicenter UnSustained Tachycardia Trial
    Andrea M Russo
    University of Pennsylvania Health System, Philadelphia, Pennsylvania 19104, USA
    J Cardiovasc Electrophysiol 15:993-8. 2004
  10. ncbi request reprint Elevated defibrillation thresholds in patients undergoing biventricular defibrillator implantation: incidence and predictors
    Sumeet K Mainigi
    Department of Medicine, Electrophysiology Section, Division of Cardiovascular Medicine, University of Pennsylvania School of Medicine, Philadelphia, 19104, USA
    Heart Rhythm 3:1010-6. 2006

Detail Information

Publications23

  1. doi request reprint Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial
    Andrea M Russo
    University of Pennsylvania Health System, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    J Cardiovasc Electrophysiol 19:720-4. 2008
    ..There are limited data regarding the influence of gender on outcome of patients receiving ICDs for primary prevention...
  2. ncbi request reprint Defibrillation threshold testing: is it really necessary at the time of implantable cardioverter-defibrillator insertion?
    Andrea M Russo
    University of Pennsylvania Health System, Philadelphia, Pennsylvania 19104, USA
    Heart Rhythm 2:456-61. 2005
    ....
  3. ncbi request reprint Incidence and predictors of very late recurrence of atrial fibrillation after ablation
    Sumeet K Mainigi
    Electrophysiology Section, Division of Cardiovascular Medicine, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    J Cardiovasc Electrophysiol 18:69-74. 2007
    ..Radiofrequency catheter ablation can effectively treat patients with refractory atrial fibrillation (AF). Very late AF recurrence (> or = 12 months post-ablation) is uncommon and may represent a unique patient cohort...
  4. doi request reprint Long-term clinical efficacy and risk of catheter ablation for atrial fibrillation in the elderly
    Erica Zado
    Cardiovascular Division, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA
    J Cardiovasc Electrophysiol 19:621-6. 2008
    ..The number of elderly patients with atrial fibrillation (AF) is increasing rapidly, and the safety and efficacy of catheter ablation in this demographic group has not been established...
  5. ncbi request reprint Surface electrocardiogram characteristics of atrial tachycardias occurring after pulmonary vein isolation
    Edward P Gerstenfeld
    Section of Cardiac Electrophysiology, Division of Cardiology, Department of Medicine, University of Pennsylvania Health System, Philadelphia, Pennsylvania 19104, USA
    Heart Rhythm 4:1136-43. 2007
    ..The purpose of this study was to describe the surface electrocardiogram (ECG) morphology of common atrial tachycardias (ATs) that occur after pulmonary vein (PV) isolation...
  6. doi request reprint Single procedure efficacy of isolating all versus arrhythmogenic pulmonary veins on long-term control of atrial fibrillation: a prospective randomized study
    Sanjay Dixit
    Cardiovascular Division, Hospital of The University of Pennsylvania and Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Heart Rhythm 5:174-81. 2008
    ..Current atrial fibrillation (AF) ablation involves isolation of all pulmonary veins (PVs) with or without additional linear lesions. However, whether such extensive ablation is necessary is unclear...
  7. doi request reprint Antiarrhythmics after ablation of atrial fibrillation (5A Study): six-month follow-up study
    Peter Leong-Sit
    Cardiac Electrophysiology Section, Cardiovascular Division, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
    Circ Arrhythm Electrophysiol 4:11-4. 2011
    ..Whether early rhythm suppression decreases longer-term arrhythmia recurrence is unknown. We now report the 6-month follow-up data from this study...
  8. doi request reprint Antiarrhythmics After Ablation of Atrial Fibrillation (5A Study)
    Jean Francois Roux
    Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA
    Circulation 120:1036-40. 2009
    ..Atrial arrhythmias are common early after atrial fibrillation (AF) ablation. We hypothesized that empirical antiarrhythmic drug (AAD) therapy for 6 weeks after AF ablation would reduce the occurrence of atrial arrhythmias...
  9. ncbi request reprint Influence of gender on arrhythmia characteristics and outcome in the Multicenter UnSustained Tachycardia Trial
    Andrea M Russo
    University of Pennsylvania Health System, Philadelphia, Pennsylvania 19104, USA
    J Cardiovasc Electrophysiol 15:993-8. 2004
    ....
  10. ncbi request reprint Elevated defibrillation thresholds in patients undergoing biventricular defibrillator implantation: incidence and predictors
    Sumeet K Mainigi
    Department of Medicine, Electrophysiology Section, Division of Cardiovascular Medicine, University of Pennsylvania School of Medicine, Philadelphia, 19104, USA
    Heart Rhythm 3:1010-6. 2006
    ..Given reported risk factors for elevated defibrillation thresholds (DFTs), patients undergoing biventricular ICD placement would be suspected of having a higher incidence of elevated DFT...
  11. ncbi request reprint Comparison of cool tip versus 8-mm tip catheter in achieving electrical isolation of pulmonary veins for long-term control of atrial fibrillation: a prospective randomized pilot study
    Sanjay Dixit
    Cardiovascular Division, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    J Cardiovasc Electrophysiol 17:1074-9. 2006
    ..To compare safety and efficacy of 8-mm versus cooled tip catheter in achieving electrical isolation (EI) of pulmonary veins (PV) for long-term control of atrial fibrillation (AF)...
  12. ncbi request reprint Characteristics of patients undergoing atrial fibrillation ablation: trends over a seven-year period 1999-2005
    Edward P Gerstenfeld
    Section of Cardiac Electrophysiology, Division of Cardiology, Department of Medicine, University of Pennsylvania Health System, Philadelphia, Pennsylvania, USA
    J Cardiovasc Electrophysiol 18:23-8. 2007
    ..Catheter ablation procedures for treating atrial fibrillation (AF) have dramatically increased since triggers of AF were first described in 1998...
  13. ncbi request reprint Predictors of success after selective pulmonary vein isolation of arrhythmogenic pulmonary veins for treatment of atrial fibrillation
    Edward P Gerstenfeld
    University of Pennsylvania Health System, Philadelphia, Pennsylvania 19104, USA
    Heart Rhythm 3:165-70. 2006
    ..Atrial fibrillation (AF) ablation procedures typically involve isolation of all pulmonary veins (PVs) in addition to adjunctive linear lesions, yet the need for such an extensive ablation strategy in all patients is unclear...
  14. ncbi request reprint Proper management of pericardial tamponade as a late complication of implantable cardiac device placement
    Glenn M Polin
    Division of Cardiology, University of Pennsylvania Health System, Philadelphia, Pennsylvania, USA
    Am J Cardiol 98:223-5. 2006
    ..Once tamponade is recognized and treated, these patients appear well at long-term follow-up, with no other device-related problems. A role for lead manipulation does not appear to exist in the standard treatment of these patients...
  15. doi request reprint Implantable cardioverter defibrillators: do women fare worse than men? Gender comparison in the INTRINSIC RV trial
    Andrea M Russo
    University of Pennsylvania, Philadelphia, Pennsylvania, USA
    J Cardiovasc Electrophysiol 20:973-8. 2009
    ..Due to limited enrollment of women in previous trials, there is a paucity of data comparing outcome and arrhythmic events in men versus women with implantable cardioverter defibrillators (ICDs)...
  16. ncbi request reprint Mechanisms of organized left atrial tachycardias occurring after pulmonary vein isolation
    Edward P Gerstenfeld
    Hospital of the University of Pennsylvania, 9 Founders Pavilion, 3400 Spruce St, Philadelphia, PA 19104, USA
    Circulation 110:1351-7. 2004
    ..This arrhythmia is frequently referred to as "left atrial flutter," but the mechanism and best ablation strategy have not been determined...
  17. ncbi request reprint Total failure to sense ventricular fibrillation with inappropriate defibrillator sensitivity adjustment
    David Lin
    Electrophysiology Service, Cardiovascular Division, University of Pennsylvania Health System, Philadelphia, Pennsylvania 19104, USA
    Pacing Clin Electrophysiol 27:1321-3. 2004
    ..We report a case of complete failure to sense ventricular fibrillation with inappropriate sensitivity adjustments. Detailed review of the parameters with induction of ventricular fibrillation must be performed to assure adequate safety...
  18. ncbi request reprint Racial differences in outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT): a comparison of whites versus blacks
    Andrea M Russo
    University of Pennsylvania Health System, Presbyterian Medical Center, Philadelphia, PA 19104, USA
    Circulation 108:67-72. 2003
    ..Previous studies have shown racial differences in risk of sudden death in patients with ischemic heart disease...
  19. ncbi request reprint Implantable cardioverter defibrillator events in patients with asymptomatic nonsustained ventricular tachycardia: is device implantation justified?
    Andrea M Russo
    University of Pennsylvania Health System, Philadelphia, Pennsylvania 19104, USA
    Pacing Clin Electrophysiol 26:2289-95. 2003
    ..These results support the need for ICD implantation for primary prevention, with attention to careful programming of the detection rate to prevent inappropriate therapy...
  20. ncbi request reprint Interactions of antiarrhythmic drugs and implantable devices in controlling ventricular tachycardia and fibrillation
    Yadavendra S Rajawat
    University of Pennsylvania, 3400 Spruce Street, 9 Founders Pavilion, Philadelphia, PA 19104, USA
    Curr Cardiol Rep 4:434-40. 2002
    ..This review summarizes the benefits and adverse effects of ICD in combination with antiarrhythmic drug therapy, and provides guidelines to ensure safe application of this hybrid therapy...
  21. ncbi request reprint The dilemma of ICD implant testing
    Charles D Swerdlow
    Division of Cardiology, Department of Medicine, Cedars Sinai Medical Center, and the David Geffen School of Medicine, UCLA, Los Angeles, California, USA
    Pacing Clin Electrophysiol 30:675-700. 2007
    ..However, implant testing is too risky in approximately 5% of recipients and may not be worth the risks in 10-30%. In 25-50% of ICD recipients, testing cannot be identified as either critical or contraindicated...
  22. ncbi request reprint Seasonal variation of mortality in the Antiarrhythmics Versus Implantable Defibrillators (AVID) study registry
    Richard L Page
    Department of Internal Medicine, Cardiology Division, University of Washington School of Medicine, Seattle, 98195, USA
    Heart Rhythm 1:435-40. 2004
    ..We postulated that the pattern of death would be nonrandom with respect to temporal variables...
  23. ncbi request reprint Should microvolt T-wave alternans be utilized routinely in selecting patients for prophylactic implantable cardioverter-defibrillator insertion in the setting of ischemic heart disease?
    Andrea M Russo
    J Am Coll Cardiol 49:59-61. 2007